De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

HC Surgical Specialists Beheer

Beheer criteriumcontroles 2/4

De CEO HC Surgical Specialists' is Sieu Min Heah, benoemd in Sep2015, heeft een ambtstermijn van 9.08 jaar. bezit rechtstreeks 41.6% van de aandelen van het bedrijf, ter waarde SGD 17.92M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 5.5 jaar en 8.1 jaar.

Belangrijke informatie

Sieu Min Heah

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	9.1yrs
Eigendom CEO	41.6%
Management gemiddelde ambtstermijn	5.5yrs
Gemiddelde ambtstermijn bestuur	8.1yrs

Recente managementupdates

Recent updates

CEO

Sieu Min Heah (60 yo)

9.1yrs

Tenure

Dr. Sieu Min Heah, MB BCh, FRCSEd (General Surgery), FAMS General Surgery, has been Chief Executive Officer and Executive Director of HC Surgical Specialists Limited since September 1, 2015.

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Sieu Min Heah	CEO & Executive Director	9.1yrs	geen gegevens	41.6% SGD 17.9m
Soo Ling Ong	Chief Financial Officer	8.7yrs	geen gegevens	geen gegevens
Josephine Tio Melissa	Chief Operating Officer	2.4yrs	geen gegevens	geen gegevens
Kok Hoong Chia	Medical Director & Executive Director	no data	geen gegevens	22.6% SGD 9.7m
Gary Ng	Head of the Internal Audit	no data	geen gegevens	geen gegevens
Hui Theng Lee	Chief Nursing Officer	1.4yrs	geen gegevens	0.065% SGD 28.0k
Moi Heyang Lin	Joint Company Secretary	no data	geen gegevens	geen gegevens
Pei Chan Tang	Joint Company Secretary	no data	geen gegevens	geen gegevens

5.5yrs

Gemiddelde duur

60yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 1B1 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5.5 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Sieu Min Heah	CEO & Executive Director	9.1yrs	geen gegevens	41.6% SGD 17.9m
Kok Hoong Chia	Medical Director & Executive Director	9.1yrs	geen gegevens	22.6% SGD 9.7m
Seng Soon Ooi	Independent Non-Executive Director	8.1yrs	geen gegevens	geen gegevens
Weng Hoe Chong	Independent Non-Executive Chairman	8.1yrs	geen gegevens	0.11% SGD 46.9k
Chye Lai Lim	Non-Independent Non-Executive Director	8.1yrs	geen gegevens	0.16% SGD 70.0k

8.1yrs

Gemiddelde duur

60yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 1B1 wordt beschouwd als ervaren (gemiddelde ambtstermijn 8.1 jaar).

HC Surgical Specialists Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

HC Surgical Specialists Limited, Annual General Meeting, Sep 30, 2024

Insufficient new directors

Insufficient new directors

HC Surgical Specialists Limited, Annual General Meeting, Sep 26, 2023

Insufficient new directors

Insufficient new directors

Recent updates

Full year 2024 earnings released: EPS: S$0.025 (vs S$0.02 in FY 2023)

HC Surgical Specialists Limited Proposes Final Dividend (Tax-Exempt One-Tier) for the Financial Year Ended 31 May 2024, Payable on 25 November 2024

New minor risk - Financial data availability

HC Surgical Specialists Limited, Annual General Meeting, Sep 30, 2024

Insufficient new directors

First half 2024 earnings released: EPS: S$0.023 (vs S$0.014 in 1H 2023)

HC Surgical Specialists Limited Declares Interim Dividend for the Financial Year Ending 31 May 2024, Payable on 13 March 2024

HC Surgical Specialists Limited Declares Interim Dividend, Payable on 13 March 2024

Insufficient new directors

Upcoming dividend of S$0.01 per share at 6.3% yield

HC Surgical Specialists Limited Approves A Final Dividend for the Financial Year Ended 31 May 2023

New minor risk - Shareholder dilution

HC Surgical Specialists Limited Proposes Final Dividend for the Financial Year Ended 31 May 2023

HC Surgical Specialists Limited, Annual General Meeting, Sep 26, 2023

Full year 2023 earnings released: EPS: S$0.019 (vs S$0.043 in FY 2022)

New minor risk - Financial data availability

Insufficient new directors

Insufficient new directors

Upcoming dividend of S$0.01 per share at 4.9% yield

HC Surgical Specialists Limited Announces Interim Dividend for the Financial Year Ending 31 May 2023, Payable on 13 March 2023

First half 2023 earnings released

Insufficient new directors

Insufficient new directors

Upcoming dividend of S$0.012 per share

HC Surgical Specialists Limited Approves Final Dividend (Tax-Exempt One-Tier) for the Financial Year Ended 31 May 2022

Now 21% undervalued after recent price drop

HC Surgical Specialists Limited, Annual General Meeting, Sep 27, 2022

Full year 2022 earnings released: EPS: S$0.043 (vs S$0.053 in FY 2021)

HC Surgical Specialists Limited Recommends Final Dividend for the Financial Year Ended May 31, 2022

HC Surgical Specialists Limited Appoints Melissa Josephine Tio @ Melissa Josephine Susantio as Chief Operating Officer, Effective 1 May 2022

Insufficient new directors

HC Surgical Specialists Limited Announces Resignation of Chief Operating Officer, Ouyang Yuxia, Connie, Effective 30 April 2022

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Upcoming dividend of S$0.023 per share

Upcoming dividend of S$0.023 per share

Full year 2021 earnings released: EPS S$0.053 (vs S$0.027 in FY 2020)

HC Surgical Specialists Limited Announces That the Court of Appeal Dismissed

First half 2021 earnings released: EPS S$0.033

New 90-day high: S$0.42

HC Surgical Specialists Limited (Catalist:1B1) agreed to acquire remaining 30% stake in Julian Ong Endoscopy & Surgery (Pte Ltd).

HC Surgical Specialists Limited (Catalist:1B1) acquired 20% stake in Healthcare Essentials Pte. Ltd. from Lim Chye Lai, Gjan for SGD 0.18 million.

HC Surgical Specialists Provides Cashless and Convenient Healthcare Services to Eligible 1 Customers of Prudential Singapore

New 90-day high: S$0.35

New 90-day high - S$0.34

Full year earnings released - EPS S$0.023

New 90-day low - S$0.29

HC Surgical Specialists Limited completed the acquisition of additional 19% stake in Julian Ong Endoscopy & Surgery (Pte Ltd) from Julian Ong Surgery Pte. Ltd. for $3.8 million.

HC Surgical Specialists Limited (Catalist:1B1) completed the acquisition of additional 19% stake in Julian Ong Endoscopy & Surgery Pte. Ltd from Julian Ong Surgery Pte. Ltd.

CEO

Tenure

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd